홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Triethylamine → 4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (4,9-dimethyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-cyclohepta[e]inden-7-yl)-amide

HRID 132469
인쇄

반응식

HRID 132469 반응식
Cl.[NH2:2][CH:3]1[C:17](=[O:18])[N:16]([CH3:19])[CH2:15][C:6]2[C:7]3[CH:8]=[N:9][NH:10][C:11]=3[C:12]([CH3:14])=[CH:13][C:5]=2[CH2:4]1.[C:20](=O)(ON1C(=O)CCC1=O)[O:21]N1C(=O)CCC1=O.C(N(CC)CC)C.Cl.[NH:46]1[CH2:51][CH2:50][CH:49]([N:52]2[CH2:61][C:60]3[C:55](=[CH:56][CH:57]=[CH:58][CH:59]=3)[NH:54][C:53]2=[O:62])[CH2:48][CH2:47]1>ClCCl>[CH3:14][C:12]1[C:11]2[NH:10][N:9]=[CH:8][C:7]=2[C:6]2[CH2:15][N:16]([CH3:19])[C:17](=[O:18])[CH:3]([NH:2][C:20]([N:46]3[CH2:47][CH2:48][CH:49]([N:52]4[CH2:61][C:60]5[C:55](=[CH:56][CH:57]=[CH:58][CH:59]=5)[NH:54][C:53]4=[O:62])[CH2:50][CH2:51]3)=[O:21])[CH2:4][C:5]=2[CH:13]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 8471TriethylamineHCID 676246Di(succinimido) carbonateHCID 183213553-(Piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one hydrochlorideHCID 1317269227-amino-4,9-dimethyl-6,7,9,10-tetrahydro-3H-2,3,9-triaza-cyclohepta[e]inden-8-one, hydrochloride

생성물 1

HCID 24783417
4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (4,9-dimethyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-cyclohepta[e]inden-7-yl)-amide

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

To a solution of (4,9-dimethyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-cyclohepta[e]inden-7-yl)-carbamic acid benzyl ester (50 mg, 0.132 mmol) in methanol and chloroform (0.5 mL) was added 10% palladium on carbon (20 mg) under nitrogen atmosphere. The reaction mixture was brought to hydrogen atmosphere (1 atm) and stirred for 3 h. The catalyst was filtered and the solvent was evaporated to give 7-amino-4,9-dimethyl-6,7,9,10-tetrahydro-3H-2,3,9-triaza-cyclohepta[e]inden-8-one, hydrochloride in almost quantitative yield. To the amine salt in dichloromethane was added disuccinimidyl carbonate (37 mg, 0.145 mmol) and triethylamine (0.11 mL, 0.8 mmol) at room temperature. After 120 min, 3-piperidin-4-yl-3,4-dihydro-1H-quinazolin-2-one, hydrochloride (39 mg, 0.145 mmol) was added and stirring continued for 12 h. The solvent was evaporated and the crude product was purified by Prep HPLC to give 4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (4,9-dimethyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-cyclohepta[e]inden-7-yl)-amide in 59% overall yield. MS (ESI) 502 (M+H); Rf=1.31.

후처리

  1. waitcontinued for 12 h
  2. customThe solvent was evaporated
  3. customthe crude product was purified by Prep HPLC

출처 및 근거

ORD 기록
ord-33dd2a2e31d64620a93c7ea1f9e9b4a4
출처 데이터셋
uspto-grants-2008_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07384931B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트